Back
Clearwater Paper 10K Form
Buy
56
CLW
Clearwater Paper
Last Price:
40.21
Seasonality Move:
19.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-10-30 | 10Q | CLW/Clearwater Paper Quarterly |
2023-08-01 | 10Q | CLW/Clearwater Paper Quarterly |
2023-05-02 | 10Q | CLW/Clearwater Paper Quarterly |
2022-10-31 | 10Q | CLW/Clearwater Paper Quarterly |
2022-08-02 | 10Q | CLW/Clearwater Paper Quarterly |
2022-04-28 | 10Q | CLW/Clearwater Paper Quarterly |
Receive CLW News And Ratings
See the #1 stock for the next 7 days that we like better than CLW
CLW Financial Statistics
Sales & Book Value
Annual Sales: | $2.08B |
---|---|
Cash Flow: | $40.5M |
Price / Cash Flow: | 5.85 |
Annual Sales: | $40.57 |
Price / Book: | 0.99 |
Profitability
EPS (TTM): | 6.33000 |
---|---|
Net Income (TTM): | $107.7M |
Gross Margin: | $330.8M |
Return on Equity: | 17.4% |
Return on Assets: | 6.33% |
Clearwater Paper Earnings Forecast
Key Clearwater Paper Financial Ratios
- The Gross Profit Margin over the past 18 years for CLW is 15.88%.
- The Selling, General & Administrative Expenses for CLW have been equal to 7.16% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 28.88% of Operating Income.
- The Net Earning history of CLW is 5.17% of Total Revenues.
- Per Share Earnings over the last 17 years have been positive in 9 years.
Clearwater Paper Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Paper & Forest Products |
Sector: | Materials |
Current Symbol: | CLW |
CUSIP: | 18538R |
Website: | clearwaterpaper.com |
Debt
Debt-to-Equity Ratio: | 0.69 |
---|---|
Current Ratio: | 1.97 |
Quick Ratio: | 0.79 |
Price-to-Earnings
Trailing P/E Ratio: | 6.39 |
---|---|
Forward P/E Ratio: | 8.33 |
CLW Technical Analysis vs Fundamental Analysis
Buy
56
Clearwater Paper (CLW)
is a Buy
Is Clearwater Paper a Buy or a Sell?
-
Clearwater Paper stock is rated a Buy
The current Clearwater Paper [CLW] share price is $40.23. The Score for CLW is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.